Compare Schemes

Merisis Catalyst Series 1 vs Polaris Human Plus Machine Converged Equity Strategy

Merisis Catalyst Series 1

Polaris Human Plus Machine Converged Equity Strategy

Add Scheme

Growth of ₹1 Crore

Merisis Catalyst Series 1

Polaris Human Plus Machine Converged Equity Strategy

1 Month

−2.20%

9.44%

6 Months

9.62%

2.42%

1 Year

—

1.29%

3 Years

—

5 Years

—

Since Inception

3.28%

23.68%

Fund Age

9 mo

4 mo

AUM

₹0.81 Cr

₹2.91 Cr

Alpha – 1 Year

—

0.33%

Alpha – 3 Years

—

Information Ratio – 3 Years

—

Volatility – 1 Year

—

Volatility – 3 Years

—

Beta – 1 Year

—

Beta – 3 Years

—

Sharpe Ratio – 1 Year

—

Sharpe Ratio – 3 Years

—

Worst Rolling Year

—

Value at Worst Rolling Year

—

Deepest Drawdown

—

Recovery Period

—

1-Year Rolling Windows Positive

—

Median Rolling Year

—

5-Year Rolling Windows Positive

—

Market-Cap Mix

S 79%

M 5% · S 92%

Number of Stocks

Portfolio P/E

32.20

67.46

Top 5 Holdings

Wockhardt Ltd · 14.44%

Ion Exchange (India) Ltd · 12.96%

Ramco Systems Ltd · 11.82%

Jubilant Ingrevia Ltd · 10.28%

Venkys (India) Ltd · 10.20%

Shilpa Medicare Ltd · 11.42%

Cash & Cash Equivalent · 7.83%

Himadri Speciality Chemical Ltd · 7.42%

Sheela Foam Ltd · 6.84%

Rubicon Research Ltd · 6.78%

Top Sectors

Healthcare · 21.28%

Fast Moving Consumer Goods · 19.84%

Utilities · 12.96%

Healthcare · 31.15%

Capital Goods · 20.12%

Chemicals · 13.97%

Fixed Fee

1.20% / yr

0.50% / yr

Performance Fee / Plan

20% of profit, above 12%

Fixed Plan

Exit Load (Y1 / Y2 / Y3)

3% / 2% / 1%

0% / 0% / 0%

Let's start a
conversation

Compare this PMS against 3,000+ others with our research desk
Build a long-term portfolio around your goals, not a one-off buy
Experts with decades of experience.

Private. Personal. No obligation.

We will only use these details to contact you about this enquiry. No spam.